Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
J7HA13
|
NANOGP8; Fragment;
|
NANOGP8;
|
NULL
|
130
|
human
|
A0A024RAV3
|
HCG1654716, isoform CRA_a;
|
NULL
|
NULL
|
93
|
human
|
Q3YB49
|
Breast and ovarian cancer susceptibility protein; Fragment;
|
BRCA1;
|
NULL
|
39
|
human
|
E9PBZ9
|
Nucleoside diphosphate-linked moiety X motif 6;
|
NUDT6;
|
NULL
|
104
|
human
|
I3L295
|
Mannose-P-dolichol utilization defect 1 protein;
|
MPDU1;
|
NULL
|
109
|
human
|
B4DLR6
|
Protocadherin-18; cDNA FLJ57393, highly similar to Protocadherin-18;
|
PCDH18;
|
NULL
|
315
|
human
|
Q8N0W1
|
Seven transmembrane helix receptor;
|
NULL
|
NULL
|
211
|
human
|
Q6L638
|
ABO glycosyltransferase; ABO-glycosyltransferase B; Fragment;
|
ABO;
|
NULL
|
229
|
human
|
J3QKN1
|
FXYD domain containing ion transport regulator 6, isoform CRA_b; FXYD domain-containing ion transport regulator 6;
|
FXYD6;
|
NULL
|
90
|
human
|
J7HBD5
|
Retinoic acid early transcript 1H; Fragment;
|
RAET1H;
|
NULL
|
93
|
human
|
Q8HC09
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1; Fragment;
|
NULL
|
NULL
|
98
|
human
|
B0QZ36
|
mRNA export factor; Fragment;
|
RAE1;
|
NULL
|
137
|
human
|
A0A024R5Q9
|
HCG1982563; HCG1982564;
|
NULL
|
NULL
|
122
|
human
|
C4N362
|
KIR3DL1; KIR3DL1/S1;
|
KIR3DL1;
|
NULL
|
444
|
human
|
A0A024RBM7
|
PR domain zinc finger protein 4; PR domain-containing protein 4;
|
PRDM4;
|
NULL
|
801
|
human
|
A0A024RDV4
|
START domain containing 13, isoform CRA_a;
|
STARD13;
|
NULL
|
1113
|
human
|
E0X074
|
KIR3DL1;
|
KIR3DL1;
|
NULL
|
444
|
human
|
H9QIJ3
|
Cytochrome c oxidase subunit 3;
|
COX3;
|
NULL
|
261
|
human
|
A0A024QZE8
|
Phosphorylase kinase, gamma 2 (Testis), isoform CRA_a;
|
PHKG2;
|
NULL
|
297
|
human
|
Q5Y7A3
|
Duffy antigen chemokine receptor; Duffy antigen/chemokine receptor; Duffy antigen/chemokine receptor isoform a; Duffy blood group;
|
FY; DARC;
|
NULL
|
338
|
human
|